Congressional Democrats continue to wrangle over a $3.5 trillion economic and social welfare bill that is expected to include major drug pricing reforms.

Rough Sailing for Drug Pricing Reform in Congress

It is unclear whether congressional Democrats will meet their self-appointed deadline to pass and send to President Biden this week a $3.5 trillion economic and social welfare bill including major drug pricing reforms.

340B covered entities worry that language that would effectively eliminate 340B savings on drugs dispensed to Medicaid managed care enrollees will be included in the bill’s drug pricing section.

It appears increasingly likely that congressional Democrats will miss their self-appointed deadline to pass and sent to President Biden this week a $3.5 trillion economic and social welfare bill including major drug pricing reforms.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report